UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 353

Sortiert nach

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

International Journal of Obesity, 2004-04, Vol.28 (4), p.640-648

2004

Volltextzugriff (PDF)

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

Molecular pharmacology, 2003-04, Vol.63 (4), p.908-914

2003

Volltextzugriff (PDF)

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Behavioural pharmacology, 2002-09, Vol.13 (5-6), p.451-463

2002

Volltextzugriff (PDF)

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Molecular psychiatry, 2004-03, Vol.9 (3), p.278-286

2004

Volltextzugriff (PDF)

Blockade of CRF1 or V1B receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Molecular psychiatry, 2004-03, Vol.9 (3), p.224-224

2004

Volltextzugriff (PDF)

Effects of CB1 Cannabinoid Receptor Blockade on Ethanol Preference After Chronic Ethanol Administration

Alcoholism, clinical and experimental research, 2001-09, Vol.25 (9), p.1317-1323

2001

Volltextzugriff (PDF)

SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats

Neuropharmacology, 2004-06, Vol.46 (8), p.1121-1129

2004

Volltextzugriff (PDF)

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

Psychopharmacologia, 2001-09, Vol.157 (3), p.254-259

2001

Volltextzugriff (PDF)

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation : an in vivo microdialysis approach in guinea pig

Neuropeptides (Edinburgh), 1998-10, Vol.32 (5), p.481-488

1998

Volltextzugriff (PDF)

Blockade of cannabinoid receptors by SR141716 selectively increases fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function

Neuroscience, 1999-06, Vol.91 (2), p.607-620

1999

Volltextzugriff (PDF)

Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra : An in vitro electrophysiological study

Neuroscience, 1997-06, Vol.78 (3), p.745-757

1997

Volltextzugriff (PDF)

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1997-02, Vol.280 (2), p.802

1997

Volltextzugriff (PDF)

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D 2 function

Neuroscience, 1999, Vol.91 (2), p.607-620

1999

Volltextzugriff (PDF)

Altered neurotensin mrna expression in mice lacking the dopamine transporter

Neuroscience, 2004, Vol.123 (2), p.537-546

2004

Volltextzugriff (PDF)

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Psychopharmacologia, 1996-07, Vol.126 (2), p.165-172

1996

Volltextzugriff (PDF)

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

Behavioural pharmacology, 1998-03, Vol.9 (2), p.179-181

1998

Volltextzugriff (PDF)

Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr 11]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens

Neuroscience, 2000, Vol.98 (3), p.485-492

2000

Volltextzugriff (PDF)

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Journal of physiology, 1998-08, Vol.510 (3), p.867-879

1998

Volltextzugriff (PDF)

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

Psychopharmacologia, 2001-11, Vol.158 (3), p.241-251

2001

Volltextzugriff (PDF)

Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: A combined in vivo electrochemical and electrophysiological study

Neuroscience, 1998-08, Vol.85 (4), p.1173-1182

1998

Volltextzugriff (PDF)

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Psychopharmacologia, 1998-02, Vol.135 (4), p.324-332

1998

Volltextzugriff (PDF)

Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons

Neuroscience, 1998-10, Vol.86 (3), p.799-811

1998

Volltextzugriff (PDF)

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice

Pharmacology, biochemistry and behavior, 1995-05, Vol.51 (1), p.3-7

1995

Volltextzugriff (PDF)

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

Behavioural pharmacology, 1996-01, Vol.7 (1), p.65-71

1996

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(211)
Science & Technology
(182)
Life Sciences & Biomedicine
(169)
Male
(167)
Rats
(145)
Biological And Medical Sciences
(128)
Neurosciences & Neurology
(106)
Neurosciences
(104)
Pharmacology & Pharmacy
(92)
Medical Sciences
(77)
Pharmacology. Drug Treatments
(67)
Mice
(66)
Neuropharmacology
(60)
Rats, Sprague-Dawley
(60)
Humans
(57)
Piperidines - Pharmacology
(57)
Fundamental And Applied Biological Sciences. Psychology
(50)
Psychology. Psychoanalysis. Psychiatry
(49)
Pyrazoles - Pharmacology
(47)
Dose-Response Relationship, Drug
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Psychopharmacology
(31)
Neuroscience
(24)
European Journal Of Pharmacology
(23)
Psychopharmacologia
(22)
Neuropeptides
(16)
The Journal Of Pharmacology And Experimental Therapeutics
(15)
Brain Research
(14)
Neuroscience Letters
(13)
Behavioural Pharmacology
(12)
Journal Of Neurochemistry
(11)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Blockade of CRF1 or V1B receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Effects of CB1 Cannabinoid Receptor Blockade on Ethanol Preference After Chronic Ethanol Administration

SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation : an in vivo microdialysis approach in guinea pig

Blockade of cannabinoid receptors by SR141716 selectively increases fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function

Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra : An in vitro electrophysiological study

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D 2 function

Altered neurotensin mrna expression in mice lacking the dopamine transporter

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr 11]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: A combined in vivo electrochemical and electrophysiological study

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

Suchergebnisse filtern